Tata Capital Healthcare Fund plans to exit over half of its portfolio companies through initial public offerings (IPOs) from its latest ₹2,500 crore fund, announced in early September 2026. The fund is shifting its exit strategy from traditional strategic sales to public listings, aiming to capitalize on favorable market conditions for healthcare companies.
The fund is increasing its ticket sizes and focusing investments on sectors such as medical devices and single-specialty healthcare chains. Visalakshi Chandramouli, managing partner at Tata Capital Healthcare Fund, highlighted the pivot towards IPO exits as a key strategy to unlock value for investors. This approach reflects a broader trend in the healthcare investment space, where public markets have shown strong appetite for specialized healthcare firms.
This shift in exit strategy is significant as it aligns with the growing interest in healthcare IPOs in India, which have seen increased activity in recent years. The fund’s focus on growth drivers like medical devices and specialty chains positions it to benefit from sector-specific expansion. Comparable funds have traditionally relied on strategic sales, but Tata Capital Healthcare Fund’s move signals confidence in the public markets’ capacity to absorb healthcare listings.
The ₹2,500 crore fund’s performance and exit outcomes will be closely watched, with the next major milestone being the first IPO exits expected within the next 12 to 18 months, according to livemint.com. The fund’s strategy could influence other healthcare-focused investment vehicles considering IPO routes for portfolio exits.